Research & Development: Page 31

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Genpact Research: AI Adoption Accelerating Trend Watch: AI Applications Grow Across the Healthcare Spectrum The adoption of AI is rapidly growing, however, to take full advantage of AI’s opportunities, businesses must understand and overcome lingering doubts from their customers and employees, ac...

    By PharmaVoice Team • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Restoring the Microbiome Todd Krueger, President and CEO of AOBiome Therapeutics, discusses the company’s research to develop therapies that aim to re-introduce beneficial bacteria to the microbiome. The human microbiome consists of trillions of microorganisms that live in and on humans and are e...

    By Todd Krueger • March 1, 2019
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Connecting Rare Disease Patients Angie Rowe, Interim Executive Director, Global Genes, talks about the 10th anniversary of the rare disease organization and its vision for the future. PV: Over the past 10 years, what impact has Global Genes had on the rare disease community? Rowe: When Nicole Boi...

    By Angie Rowe • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hacking the Biopharma Industry

    Biopharmaceutical companies and their partners are taking a page from Silicon Valley by sponsoring hackathons and competitions to drive innovation in research and develop new solutions for patients. Pharma companies are reaching outside their own walls to discover innovative new ways to improve t...

    By Denise Myshko • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Wearables In Clinical Trials

    Wearables are improving the clinical trial experience for patients and satisfying the need to collect data for real-world use studies. Experts agree: future drug development will be based on broader, real-time patient data. Connected health, which includes wearable devices and mobile health (mHea...

    By Denise Myshko • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Red Zone: Innovation from the Inside Out

    In November 2018, Cognizant was proud to introduce two new products into the Life Sciences market. Both came out of our Accelerator LaunchPad program, which solicits ideas, creates internal startups, and launches only those products that can survive and thrive throughout its rigorous process. But...

    By Ari Srinivasan • March 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Agile Transformation By definition change is hard, and anyone who works for a large or even a small company has been through at least one reorganization. The agility that companies will need to compete in the new economy, one defined by the digitization of healthcare, cannot be underestimated, an...

    By Taren Grom • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Harnessing the Power of the Body’s Electrical System Frank Amato, CEO of electroCore, talks about how vagus nerve stimulation can be used for the preventive treatment of cluster headache and for the relief of pain associated with migraine and episodic cluster headache. Our nervous system interact...

    By Frank Amato • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Bayer Uses AI to Boost Pharmacovigilance Trend Watch: Pharma Use of AI Increases In an effort to accelerate its patient safety data monitoring by using artificial intelligence, Bayer has partnered with Genpact to employ its Pharmacovigilance Artificial Intelligence (PVAI) products. These AI tools...

    By PharmaVoice Team • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Transformation: Ready, Set, Agile

    According to McKinsey, companies that have enterprise agility share some commonalities: a North Star-mentality, in other words an overarching customer strategy; a scalable team structure; a rapid decision-making mentality; a dynamic people model that ignites passion; and a willing adoption of nex...

    By PharmaVoice Team • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Red Zone: Disruptive Innovation: Questions for the C-Suite

    It is not the strongest of the species that survives, nor is it the most intelligent. It is the one that is most adaptable to change. Whether a direct quote from Charles Darwin or a summary of his writings, this statement is perhaps the most profound scientific explanation of life itself, in all ...

    By Srini Shankar • Feb. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Artificial Intelligence Happy New Year. As we enter 2019, we take note of one of the major trends expected to impact all aspects of the life-sciences industry: artificial intelligence. In 2019, according to Forrester, AI solutions will continue to spread across the healthcare continuum thanks to ...

    By Taren Grom • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Medicinal Theater BioMarin Pharmaceutical and Believe Ltd. sponsored a first-of-its-kind theatrical production for teenagers with hemophilia. The musical, Hemophilia: The Musical, took place at New World Stages on Nov. 12, 2018. Before the performance, students participated in the Breaking Throug...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    Payers Use Healthtech to Improve Patient Outcomes, Lower Costs Trend Watch: Healthtech Mobile App Market Continues To Grow Payers Offer Free Wearables UnitedHealthcare, Aetna, and John Hancock have all implemented programs that offer free Apple Watches to customers, if they exercise daily. The la...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence

    Artificial Intelligence Key to Improving Healthcare Quality, Reducing Costs Trend Watch: AI Implications for Healthcare are Widespread Artificial Intelligence (AI) is key to building a better healthcare future, according to a recent survey of 500 U.S. healthcare leaders on their attitudes and usa...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovator's Corner

    Modifying the Immune Response in Celiac Leslie Williams, CEO of ImmusanT, discusses the company’s research for developing a disease-modifying therapeutic for patients with celiac disease. Celiac disease is often misunderstood as a lifestyle disease. Unmanaged, celiac can result in chronic anemia,...

    By Leslie Williams • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Artificial Intelligence: Molecule to Market

    The adoption of artificial intelligence (AI) is rapidly taking hold across global businesses, including the life-sciences industry. AI is typically defined as the ability of a machine to perform cognitive functions associated with human minds, such as perceiving, reasoning, learning, and problem ...

    By PharmaVoice Team • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Coming Wave of Cannabis-based Medicines

    Cannabis has remained a source of controversy — from debates on its medicinal value and legalization to concerns about dependency. Cannabis is a hot-button issue among patients, healthcare practitioners, and policymakers. But that is changing. In fact, 32 states and Washington, D.C., now allow ma...

    By Denise Myshko • Jan. 1, 2019
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The year ahead… As we come to the end of 2018, it’s important to pause and reflect on not just where we’ve been, but where we are going as an industry. In 2018, we saw continuing uncertainty in terms of the Affordable Care Act. We welcomed Alex Azar as the new Secretary of Health and Human Servic...

    By Taren Grom • Nov. 15, 2018
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    Johnson & Johnson Announces 10-year Initiative to Help End Tuberculosis Johnson & Johnson has announced a comprehensive 10-year initiative in support of the United Nations’ Sustainable Development Goal target of ending the TB pandemic by 2030. With the goal of saving an estimated 1.8 mill...

    By PharmaVoice Team • Nov. 15, 2018
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HealthTech

    Nanomedicine Zeros In On Triple Negative Breast Cancer Cells Trend Watch: From Breast Cancer to Asthma, Healthtech Tools Develop Care Solutions Researchers at George Washington University have shown that a technique of delivering a chemotherapy agent within specially designed nanoparticles can be...

    By PharmaVoice Team • Nov. 15, 2018
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2019 Trend Tracking

    In this special 2019 Year in Preview issue, more than 100 PharmaVOICE thought leaders address 10 trends that are expected to be part of the changing landscape in the year ahead. These areas of focus cover a variety of disparate topics that range from molecule to market in keeping with our publish...

    By Taren Grom • Nov. 15, 2018
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Looking Forward To

    AI Adoption Richard Davies VP, Solution Expert, CluePoints The application of artificial intelligence and machine learning within the R&D process to guide disparate stakeholders through the planning and execution of clinical trials through targeted risk management is both a current capability...

    By Taren Grom • Nov. 15, 2018
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Trend: 3D and Bioprinting

    The bioprinting field continues to grow and mature. With the evolution of the technology, experts believe even broader applications are on the horizon, providing patients with fully functioning cells — and even organs — that have been created through bioprinting processes. “All of us can envision...

    By Denise Myshko • Nov. 15, 2018
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Trend: Advanced Diagnostics and Precision Medicine

    Healthcare is moving increasingly toward personalized approaches — tailoring treatment based on each patient’s unique disease. Precision medicine is well-established in oncology, with many cancers now characterized by their unique genomic alterations. In the past few years, the Food and Drug Admi...

    By PharmaVoice Team • Nov. 15, 2018